Selected studies of daunorubicin in adult acute nonlymphocytic leukemia.
暂无分享,去创建一个
[1] R. O'reilly. Allogenic bone marrow transplantation: current status and future directions. , 1983, Blood.
[2] C. Schiffer,et al. Evaluation of levamisole as an adjuvant to chemotherapy for treatment of ANLL , 1983, Cancer.
[3] N. Nissen,et al. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. , 1982, Blood.
[4] C. Bloomfield,et al. Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. , 1981, Blood.
[5] C. Spurr,et al. A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia. , 1979, Medical and pediatric oncology.
[6] J. Smyth,et al. The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukaemia. , 1976, European journal of cancer.
[7] M. Boiron,et al. Daunorubicin in the therapy of acute granulocytic leukemia. , 1973, Cancer research.
[8] R. Benjamin,et al. High‐dose daunorubicin therapy for acute nonlymphocytic leukemia: Correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity , 1972, Cancer.
[9] P. Wiernik,et al. A randomized clinical trial of daunorubicin and a combination of prednisone, vincristine, 6-mercaptopurine, and methotrexate in adult acute nonlymphocytic leukemia. , 1972, Cancer research.
[10] M. Boiron,et al. Daunorubicin in the treatment of acute myelocytic leukaemia. , 1969, Lancet.